secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2025-07-18T23:59:59+00:00
Accession:  0001823239-25-000099
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences dismisses EY, appoints Deloitte; material weakness disclosed
--------------------------------------------------------------------------------

- EY dismissed as auditor; Deloitte appointed effective July 16, 2025 for FY 2025.
- EY's audit reports on financial statements for 2023 and 2024 were unqualified.
- EY's internal control report for 2024 contained an adverse opinion citing material weaknesses in revenue/AR and goodwill impairment.
- No disagreements on accounting principles or reportable events other than the internal control weakness.
- Company did not consult Deloitte before the appointment; EY letter filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000099/0001823239-25-000099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000099/mrvi-20250716.htm
  HTML page:      https://secwatch.observer/filing/0001823239-25-000099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer